Both bipolar depression and refractory unipolar depression are highly difficult to treat. Because few randomized controlled trials (RCTs) address these conditions, clinicians often try medications either from the same class as proven-effective agents or that are effective for related conditions. These two large, well-conducted RCTs remind us that such clinical strategies may be neither sound nor effective.What Lamotrigine and Ziprasidone Are Not Good For
вторник, 20 декабря 2011 г.
Отсутствие эффективности в РКИ: зипрасидон при биполярной депрессии и ламотриджин при депрессии
Подписаться на:
Комментарии к сообщению (Atom)
Комментариев нет:
Отправить комментарий